Related Experiment Video
Updated: Sep 2, 2025

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Platelet TGF-β1 inhibits the migration and proliferation of smooth muscle cells in aneurysms
Xiaowei Liu1, Cheng Xu2, Jiangjie Lou1
1Department of Cardiology, Zhejiang Hospital, China.
Background:
The study explored the role of platelet TGF-β1 from the perspective of inhibiting the excessive proliferation, migration and invasion of murine aortic vascular smooth muscle cells (MASMCs).
Method:
The platelets were first extracted from C57BL/6 mice, and the TGF-β1 protein was obtained after the purification of protein. In vitro, the concentrations of angiotensin Ⅱ (Ang Ⅱ) and TGF-β1 for intervention were screened by testing the viability of MASMCs, followed by the analysis concerning the effects of platelets, Ang Ⅱ and TGF-β1 on the proliferation, migration, invasion, and the expressions of pathway-related proteins in MASMCs. In vivo, an Ang Ⅱ-induced mouse model was established. TGF-β1 was injected into the tail of mice as a therapeutic agent, and its action mechanism was further verified by the treatment of inhibitor SB505124. The results of the cell experiment were validated by evaluating the maximum diameter of abdominal aorta, the proportion of total weight, the changes of both pathology and the expressions of pathway-related proteins in the mice.
Result:
0.5 ng/mL Ang Ⅱ and 15 ng/mL TGF-β1 were chosen for treatment. The following results of cell functional experiments and Western blot assay demonstrated that Ang Ⅱ promoted the proliferation, migration and invasion of MASMCs via regulating related pathways, the effects of which were evidently reversed by TGF-β1 and platelets. Consistent results were also observed in the animal experiments, where TGF-β1 effectively alleviated Ang Ⅱ-induced abdominal aortic injury in mice.
Conclusion:
TGF-β1 in platelets inhibits Ang Ⅱ-induced proliferation, migration and invasion of MASMCs.
Insights
Platelet transforming growth factor-beta 1 (TGF-β1) inhibits angiotensin II (Ang II)-induced vascular smooth muscle cell dysfunction. This finding offers potential therapeutic insights for aortic injury by demonstrating TGF-β1
Area of Science:
- Cardiovascular Biology
- Vascular Cell Biology
- Platelet Physiology
Background:
- Excessive proliferation, migration, and invasion of murine aortic vascular smooth muscle cells (MASMCs) contribute to vascular disease.
- Platelet-derived growth factors play a critical role in regulating vascular cell behavior.
- Understanding the specific roles of platelet components, like TGF-β1, is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the inhibitory role of platelet-derived transforming growth factor-beta 1 (TGF-β1) on angiotensin II (Ang II)-induced MASMC dysfunction.
- To explore the therapeutic potential of TGF-β1 in mitigating Ang II-induced vascular injury in vivo.
- To elucidate the molecular mechanisms underlying TGF-β1's effects on MASMCs.
Main Methods:
- MASMCs were treated with varying concentrations of Ang II and TGF-β1 to determine optimal intervention levels.
- In vitro experiments assessed the effects of platelets, Ang II, and TGF-β1 on MASMC proliferation, migration, and invasion using cell-based assays and Western blotting.
- An in vivo Ang II-induced mouse model was used to evaluate the therapeutic efficacy of TGF-β1, with mechanistic insights gained from inhibitor studies and pathological analysis.
Main Results:
- Ang II significantly promoted MASMC proliferation, migration, and invasion by modulating related signaling pathways.
- Exogenous TGF-β1 and platelet treatment effectively reversed the pro-proliferative, migratory, and invasive effects of Ang II on MASMCs.
- In vivo, TGF-β1 administration demonstrated a protective effect against Ang II-induced abdominal aortic injury in mice, consistent with in vitro findings.
Conclusions:
- Platelet-derived TGF-β1 acts as a key inhibitor of Ang II-induced MASMC proliferation, migration, and invasion.
- TGF-β1 holds therapeutic promise for treating vascular pathologies driven by Ang II signaling.
- The study highlights the critical role of platelet components in vascular homeostasis and disease modulation.
More Related Videos
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
Clot Retraction and Fibrinolysis
Atherosclerosis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Intracellular Signaling Affects Focal Adhesions
Some...
Vascular Spasm
Cytoskeletal Coordination in Cell Migration